Please try another search
DMCC Speciality Chemicals Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 839.59 million compared to INR 965.03 million a year ago. Revenue was INR 932.49 million compared to INR 972.95 million a year ago. Net income was INR 57.73 million compared to INR 66.95 million a year ago. Basic earnings per share from continuing operations was INR 2.31 compared to INR 2.68 a year ago. Diluted earnings per share from continuing operations was INR 2.31 compared to INR 2.68 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 839.59 | 805.28 | 765.24 | 855.9 |
Gross Profit | 243.52 | 238.16 | 260.72 | 266.06 |
Operating Income | 31.77 | 55.88 | 73.79 | |
Net Income | 57.73 | 3.07 | 23.72 | 31.36 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 3772.67 | 3835.64 | ||
Total Liabilities | 1677.32 | 1798.83 | ||
Total Equity | 2095.35 | 2036.81 | 2036.81 | 1982.54 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review